Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rosa Maria Moresco 2"'
Autor:
Silvia Valtorta* 1, 2, Massimo Moro* 3, Giovanna Prisinzano 1, 4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3, Rosa Maria Moresco +2, 4 *Contributed equally to this work. +Contributed equally to this work.
Publikováno v:
The Journal of nuclear medicine (1978) 58 (2017): 42–47. doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta* 1,2, Massimo Moro* 3, Giovanna Prisinzano 1,4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2,4, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3 and Rosa Maria Moresco +2,4 *Contributed equally to this work. +Contributed equally to this work./titolo:Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response./doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978)/anno:2017/pagina_da:42/pagina_a:47/intervallo_pagine:42–47/volume:58
The Journal of nuclear medicine (1978. Online) (2016). doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta, Massimo Moro, Giovanna Prisinzano, Giulia Bertolini, Monica Tortoreto, Isabella Raccagni, Ugo Pastorino, Luca Roz, Gabriella Sozzi, and Rosa Maria Moresco/titolo:Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response/doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978. Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Silvia Valtorta* 1,2, Massimo Moro* 3, Giovanna Prisinzano 1,4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2,4, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3 and Rosa Maria Moresco +2,4 *Contributed equally to this work. +Contributed equally to this work./titolo:Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response./doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978)/anno:2017/pagina_da:42/pagina_a:47/intervallo_pagine:42–47/volume:58
The Journal of nuclear medicine (1978. Online) (2016). doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta, Massimo Moro, Giovanna Prisinzano, Giulia Bertolini, Monica Tortoreto, Isabella Raccagni, Ugo Pastorino, Luca Roz, Gabriella Sozzi, and Rosa Maria Moresco/titolo:Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response/doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978. Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
PURPOSE: Lung cancer heterogeneity makes response to therapy extremely hard to predict. Patient-derived xenografts (PDXs) represent a reliable preclinical model that closely recapitulates the main characteristics of the primary tumor and could repres
Autor:
Daniela Gaglio 1, 2, 6, 8, Silvia Valtorta 1, 3, 4, Marilena Ripamonti 1, Marcella Bonanomi 2, Chiara Damiani 2, Sergio Todde 5, Alfredo Simone Negri 6, Francesca Sanvito 7, Fabrizia Mastroianni 2, Antonella Di Campli 8, Gabriele Turacchio 8, Giuseppe Di Grigoli 1, Sara Belloli 1, Alberto Luini 8, Maria Carla Gilardi 1, Anna Maria Colangelo 2, 9, Lilia Alberghina 2, Rosa Maria Moresco 2
Publikováno v:
Oncotarget
Oncotarget 7 (2016): 52017–52031. doi:10.18632/oncotarget.10470
info:cnr-pdr/source/autori:Daniela Gaglio 1,2,6,8, Silvia Valtorta 1,2,3,4, Marilena Ripamonti 1,2, Marcella Bonanomi 2, Chiara Damiani 2, Sergio Todde 5, Alfredo Simone Negri 6, Francesca Sanvito 7, Fabrizia Mastroianni 2, Antonella Di Campli 8, Gabriele Turacchio 8, Giuseppe Di Grigoli 1,2,3, Sara Belloli 1,2,3, Alberto Luini 8, Maria Carla Gilardi 1,2, Anna Maria Colangelo 2,9, Lilia Alberghina 2,9,*, Rosa Maria Moresco 2,3,4,*/titolo:Divergent in vitro%2Fin vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study./doi:10.18632%2Foncotarget.10470/rivista:Oncotarget/anno:2016/pagina_da:52017/pagina_a:52031/intervallo_pagine:52017–52031/volume:7
Oncotarget 7 (2016): 52017–52031. doi:10.18632/oncotarget.10470
info:cnr-pdr/source/autori:Daniela Gaglio 1,2,6,8, Silvia Valtorta 1,2,3,4, Marilena Ripamonti 1,2, Marcella Bonanomi 2, Chiara Damiani 2, Sergio Todde 5, Alfredo Simone Negri 6, Francesca Sanvito 7, Fabrizia Mastroianni 2, Antonella Di Campli 8, Gabriele Turacchio 8, Giuseppe Di Grigoli 1,2,3, Sara Belloli 1,2,3, Alberto Luini 8, Maria Carla Gilardi 1,2, Anna Maria Colangelo 2,9, Lilia Alberghina 2,9,*, Rosa Maria Moresco 2,3,4,*/titolo:Divergent in vitro%2Fin vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study./doi:10.18632%2Foncotarget.10470/rivista:Oncotarget/anno:2016/pagina_da:52017/pagina_a:52031/intervallo_pagine:52017–52031/volume:7
// Daniela Gaglio 1, 2, 6, 8 , Silvia Valtorta 1, 2, 3, 4 , Marilena Ripamonti 1, 2 , Marcella Bonanomi 2 , Chiara Damiani 2 , Sergio Todde 5 , Alfredo Simone Negri 6 , Francesca Sanvito 7 , Fabrizia Mastroianni 2 , Antonella Di Campli 8 , Gabriele T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208f8a2016f679f3ba7748d6357d2218
http://hdl.handle.net/10281/119849
http://hdl.handle.net/10281/119849